Ms Hu Yuan Qiong
Bachelor of Law (Shandong University), Master of Law (Shandong University), LLM (SOAS), MPhil (University of Oslo)
Graduate Teaching Assistant
Tutor, Multinational Enterprises in a Globalising World
- Ms Hu Yuan Qiong
- Email address:
- Thesis title:
- Transforming Patent Paradigm for Essential Health Innovation: Alternative Conceptual Framework Building towards Open Innovation (working title)
- Year of Study:
- Year of Entry: 2013-14
HU Yuanqiong is a lawyer and researcher on intellectual property law, international law, environmental law and human rights. She works as Legal and Policy Advisor for Access Campaign of Médecins Sans Frontières (MSF) with focus on intellectual property, and has worked as Head of Policy and Research Division of Save the Children China, and Environmental Law Attorney of Natural Resources Defence Council (US). She is a member of Law, Environment and Development Centre (LEDC) of SOAS, the Founder and Coordinator of China Access to Medicines Research Group. In addition, she has conducted consultancies for Asia and Pacific Regional Office of United Nations Development Programme (UNDP), MSF and Third World Network on patent and access to medicines, and for Save the Children UK on post-2015 development policies.
Yuan has published a number of academic articles and book chapter related to intellectual property, innovation and health. These include articles of “Towards Innovation With Access: Policies and Proposals for Reforming the Global System of Medical R&D”, Patent Law Research 239-249(2009), “Research and Development in Global Public Health: towards Access to All Essential Medicines for All”, Patent Law Research 111-127(2008), “Comment on the Implementation of ‘August 30th System’ of WTO---Taking the MSF’s Use of Canadian Access to Medicines Regime as an Example”, Patent Law Research 196-209 (2007), “Out-of-pocket Costs of AIDS in China: Are Free Antiretroviral Drugs Enough?”,20(8) AIDS Care, 984 – 994 (2008), and book chapter of “Multi-sector Approaches on Improving Access to ARVs in China”in ABIA (ed.) Intellectual Property Rights and Access to ARV Medicines: Civil Society Resistance in the Global South 82-110 (Brazil, 2009) . She has published commentaries such as “Pharmaceutical Patenting: Incentive for Innovation or Indulgence to Monopoly? A Continued Myth”,49 China Development Brief 59-62 (2011), and “The Road to Life: Insights into Advocacy Experiences of Thai HIV/AIDS Activism”, 49 China Development Brief, 54-59(2011). Her previous publications also touched upon other legal areas such as “Special Subjects of Law on the Contract of Gift: As a Tentative Proposal of Legislation” 25 Civil and Commercial Law Review, 380-420 (2002), “The Powers and Weaknesses of Online Privacy Legislative Protection: Based on Introduction and Analysis of the U.S. Children’s Online Privacy Protection Act1998” 4 Cyber Law Review 152-186(2004), and “Juvenile Justice Reform and Child Protection System: a China Case Study’ in Ko Ling Chan (ed.) Child Protection in Chinese Societies: Challenges and Policies 95-118 (Nova Publisher 2012).
“Moving Away or Shifting Within? Review of New Trends of Critiques on Law and Economics Justification of Patent from Perspective of Health Innovation”, at SOAS Law PhD Colloquium 2015, School of Oriental and African Studies, May 21, 2015
“Politics of Voluntary License on Pharmaceutical Patents: A Preliminary Discussion”, at Socio-Legal Studies Association (SLSA) 2015 Conference, University of Warwick, April 02, 2015
“Enough for Innovation? Discussion on Research and Experimental Exception of Patent in the Context of Medical Innovation”, at University College Dublin, Sutherland School of Law, Postgraduate Workshop, May 23, 2014.
“Forum of Resistance through a Comparative Lens: Access to Medicines and Patent Law Reform in India and China”, Panel on Private vs. Public Interests in Patent over Biotechnology: Implications on Developed and Developing Countries, Edinburgh Postgraduate Law Conference on ‘Law, Individual, Community’, University of Edinburgh, UK, 2 December, 2013
- “Battle with the Invisibles: Pharmaceutical Patent in China and the Impact on Access to Medicines”, Track 3: Intellectual Property and the Public Interest: Global Questions, Local Answers, The 3rd Global Congress on IP and the Public Interest, Cape Town, South Africa, 11 December, 2013
“One Year of Openness: Environmental Information Disclosure Laws in China and Pollution Information Transparency Index (PITI)”, The 7th Colloquium of The IUCN Academy of Environmental Law, November 4, 2009
- Panellist, WTO Public Forum 2015, “The TRIPS Agreement, Innovation & Access to Medicines: 20 Years On”, 02 October, 2015.
- Lecturer, WIPO-WTO Advanced Course on Intellectual Property for Governmental Officials, 23 March, 2015
- Panellist, “Philanthropy and Intellectual Property: Access to Drugs in Developing Countries”, Philanthropy Series, Law School, University of Geneva, 13 March, 2015 (Forthcoming).
- Chair, World Trade Organization Public Forum 2014 Series, “Innovation Hubs for the 21st Century: New Approaches to University IP Management ”, 01 October, 2014
- SOAS Law, Development and Development Centre, Seminar on “Ensuring Innovation and Equitable Access to Medicines: Challenges and Possibilities for a New Global Framework for R&D” with Dr Suerie Moon from Harvard University, 24 October, 2013
- MIP European Patent Reform Forum, Munich, September 08, 2015
- MIP IP in Asia Forum 2015, London, June 09, 2015
- The 5th MIP International Patent Forum, London, March 10-11, 2015
- Law, Environment and Development Journal (LEAD), SOAS
- The Society of Legal Scholars (SLS), UK
- Socio-Legal Studies Association (SLSA), UK
- All China Lawyers Association
- China Access to Medicines Research Group
- Médecins Sans Frontières Hong Kong Association
- International law
- Intellectual property law
- Intellectual property and innovation policies
- Science and Technology Studies
- Environmental law
- International political economy
- Human rights